https://orcid.org/0000-0003-3614-5538
References
- Amatya E, Fois R, Williams KA, et al. Potential for detection of safety signals for over-the-Counter medicines using national ADR spontaneous reporting data: the example of OTC NSAID-Associated gastrointestinal bleeding. Pharmacy (Basel). 2020;8(3):174.
- Guirguis-Blake JM, Evans CV, Senger CA, et al. Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive services task force. Ann Intern Med. 2016;164(12):804–813.
- Kim JS, Kim BW, Kim DH, et al. Guidelines for nonvariceal upper gastrointestinal bleeding. Gut Liver. 2020;14(5):560–570.
- Gralnek IM, Stanley AJ, Morris AJ, et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European society of gastrointestinal endoscopy (ESGE) Guideline - Update 2021. Endoscopy. 2021;53(3):300–332.
- Pollard TJ, Johnson AEW, Raffa JD, et al. The eICU collaborative research database, a freely available multi-center database for critical care research. Sci Data. 2018;5:180178.
- Sugawara M, Goto Y, Yamazaki T, Japanese Primary Prevention Project (JPPP) Study Group, et al. Low-Dose aspirin for primary prevention of cardiovascular events in elderly Japanese patients with atherosclerotic risk factors: Subanalysis of a randomized clinical trial (JPPP-70). Am J Cardiovasc Drugs. 2019;19(3):299–311.
- Wehbeh A, Tamim HM, Abu Daya H, et al. Aspirin has a protective effect against adverse outcomes in patients with nonvariceal upper gastrointestinal bleeding. Dig Dis Sci. 2015;60(7):2077–2087.
- Ahsberg K, Hoglund P. Stael von holstein C: Mortality from peptic ulcer bleeding: the impact of comorbidity and the use of drugs that promote bleeding. Aliment Pharmacol Ther. 2010;32(6):801–810.
- Sung JJ, Lau JY, Ching JY, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010;152(1):1–9.
- Dunne PDJ, Laursen SB, Laine L, et al. Previous use of antithrombotic agents reduces mortality and length of hospital stay in patients with high-risk upper gastrointestinal bleeding. Clinical Gastroenterol Hepatol. 2019;17(3):440–447. e442.
- Little D, Chai-Adisaksopha C, Hillis C, et al. Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: a systematic review and meta-analysis. Thromb Res. 2019;175:102–109.
- Lanas A, Dumonceau JM, Hunt RH, et al. Non-variceal upper gastrointestinal bleeding. Nat Rev Dis Primers. 2018;4:18020.
- Thandassery RB, Sharma M, John AK, et al. Clinical application of AIMS65 scores to predict outcomes in patients with upper gastrointestinal hemorrhage. Clin Endosc. 2015;48(5):380–384.